• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4833924)   Today's Articles (5714)
For: Zhu BD, Qie YQ, Wang JL, Zhang Y, Wang QZ, Xu Y, Wang HH. Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis. Eur J Pharm Biopharm 2007;66:318-26. [PMID: 17280823 DOI: 10.1016/j.ejpb.2006.11.028] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2005] [Revised: 07/10/2006] [Accepted: 11/27/2006] [Indexed: 11/20/2022]
Number Cited by Other Article(s)
1
VIJAYARANI K, SUDHA S, ABIRAMI B, PRIYADHARSHINI CV, KUMANAN K. Immunogenicity of chitosan coupled heat killed and fusion protein vaccine of Mycobacterium avium subsp. paratuberculosis. THE INDIAN JOURNAL OF ANIMAL SCIENCES 2021. [DOI: 10.56093/ijans.v91i6.115446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
2
Prime Vaccination with Chitosan-Coated Phipps BCG and Boosting with CFP-PLGA against Tuberculosis in a Goat Model. Animals (Basel) 2021;11:ani11041046. [PMID: 33917739 PMCID: PMC8068168 DOI: 10.3390/ani11041046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2021] [Revised: 03/30/2021] [Accepted: 04/02/2021] [Indexed: 11/21/2022]  Open
3
Yousefi S, Abbassi-Daloii T, Tahmoorespur M, Sekhavati MH. Nanoparticle or conventional adjuvants: which one improves immune response against Brucellosis? IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES 2019;22:360-366. [PMID: 31168339 PMCID: PMC6535204 DOI: 10.22038/ijbms.2019.31748.7642] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
4
Khademi F, Taheri RA, Yousefi Avarvand A, Vaez H, Momtazi-Borojeni AA, Soleimanpour S. Are chitosan natural polymers suitable as adjuvant/delivery system for anti-tuberculosis vaccines? Microb Pathog 2018;121:218-223. [DOI: 10.1016/j.micpath.2018.05.035] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2018] [Revised: 05/08/2018] [Accepted: 05/22/2018] [Indexed: 02/08/2023]
5
Mokhtar H, Biffar L, Somavarapu S, Frossard JP, McGowan S, Pedrera M, Strong R, Edwards JC, Garcia-Durán M, Rodriguez MJ, Stewart GR, Steinbach F, Graham SP. Evaluation of hydrophobic chitosan-based particulate formulations of porcine reproductive and respiratory syndrome virus vaccine candidate T cell antigens. Vet Microbiol 2017;209:66-74. [PMID: 28228336 DOI: 10.1016/j.vetmic.2017.01.037] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2016] [Revised: 12/21/2016] [Accepted: 01/30/2017] [Indexed: 01/06/2023]
6
Kumar V, Leekha A, Tyagi A, Kaul A, Mishra AK, Verma AK. Preparation and evaluation of biopolymeric nanoparticles as drug delivery system in effective treatment of rheumatoid arthritis. Pharm Res 2017;34:654-667. [DOI: 10.1007/s11095-016-2094-y] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2016] [Accepted: 12/28/2016] [Indexed: 12/16/2022]
7
Benito-Miguel M, Blanco MD, Gómez C. Assessment of sequential combination of 5-fluorouracil-loaded-chitosan-nanoparticles and ALA-photodynamic therapy on HeLa cell line. Photodiagnosis Photodyn Ther 2015;12:466-75. [PMID: 25976508 DOI: 10.1016/j.pdpdt.2015.05.001] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2015] [Revised: 04/29/2015] [Accepted: 05/04/2015] [Indexed: 11/27/2022]
8
Ganguly K, Chaturvedi K, More UA, Nadagouda MN, Aminabhavi TM. Polysaccharide-based micro/nanohydrogels for delivering macromolecular therapeutics. J Control Release 2014;193:162-73. [DOI: 10.1016/j.jconrel.2014.05.014] [Citation(s) in RCA: 106] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2014] [Revised: 05/02/2014] [Accepted: 05/07/2014] [Indexed: 01/01/2023]
9
Garg NK, Dwivedi P, Jain A, Tyagi S, Sahu T, Tyagi RK. Development of novel carrier(s) mediated tuberculosis vaccine: more than a tour de force. Eur J Pharm Sci 2014;62:227-242. [PMID: 24909731 DOI: 10.1016/j.ejps.2014.05.028] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2013] [Revised: 04/05/2014] [Accepted: 05/28/2014] [Indexed: 02/07/2023]
10
Li N, Cao N, Niu YD, Bai XH, Lu J, Sun Y, Yu M, Sun LX, Duan XS. Effects of the polysaccharide nucleic acid fraction of bacillus Calmette-Guérin on the production of interleukin-2 and interleukin-10 in the peripheral blood lymphocytes of patients with chronic idiopathic urticaria. Biomed Rep 2013;1:713-718. [PMID: 24649015 DOI: 10.3892/br.2013.130] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2013] [Accepted: 07/03/2013] [Indexed: 11/05/2022]  Open
11
Meerak J, Wanichwecharungruang SP, Palaga T. Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system. Vaccine 2013;31:784-90. [DOI: 10.1016/j.vaccine.2012.11.075] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2012] [Revised: 11/20/2012] [Accepted: 11/26/2012] [Indexed: 01/07/2023]
12
Rocha Soares KS, Cardozo Fonseca JL, Oliveira Bitencourt MA, Santos KS, Silva-Júnior AA, Fernandes-Pedrosa MF. Serum production against Tityus serrulatus scorpion venom using cross-linked chitosan nanoparticles as immunoadjuvant. Toxicon 2012;60:1349-54. [DOI: 10.1016/j.toxicon.2012.09.010] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2012] [Accepted: 09/11/2012] [Indexed: 11/28/2022]
13
Kammona O, Kiparissides C. Recent advances in nanocarrier-based mucosal delivery of biomolecules. J Control Release 2012;161:781-94. [PMID: 22659331 DOI: 10.1016/j.jconrel.2012.05.040] [Citation(s) in RCA: 88] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2012] [Revised: 05/21/2012] [Accepted: 05/22/2012] [Indexed: 01/20/2023]
14
Büyüktimkin B, Wang Q, Kiptoo P, Stewart JM, Berkland C, Siahaan TJ. Vaccine-like controlled-release delivery of an immunomodulating peptide to treat experimental autoimmune encephalomyelitis. Mol Pharm 2012;9:979-85. [PMID: 22375937 DOI: 10.1021/mp200614q] [Citation(s) in RCA: 55] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
15
Luo Y, Jiang W, Da Z, Wang B, Hu L, Zhang Y, An R, Yu H, Sun H, Tang K, Tang Z, Wang Y, Jing T, Zhu B. Subunit Vaccine Candidate AMM Down-Regulated the Regulatory T Cells and Enhanced the Protective Immunity of BCG on a Suitable Schedule. Scand J Immunol 2012;75:293-300. [DOI: 10.1111/j.1365-3083.2011.02666.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
16
Sharma S, Mukkur TK, Benson HA, Chen Y. Enhanced Immune Response Against Pertussis Toxoid by IgA-Loaded Chitosan–Dextran Sulfate Nanoparticles. J Pharm Sci 2012;101:233-44. [DOI: 10.1002/jps.22763] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2011] [Revised: 08/12/2011] [Accepted: 08/30/2011] [Indexed: 12/11/2022]
17
Li Q, Yu H, Zhang Y, Wang B, Jiang W, Da Z, Xian Q, Wang Y, Liu X, Zhu B. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice. Scand J Immunol 2011;73:568-76. [PMID: 21323695 DOI: 10.1111/j.1365-3083.2011.02531.x] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
18
Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice. Mar Drugs 2011;9:1038-1055. [PMID: 21747747 PMCID: PMC3131560 DOI: 10.3390/md9061038] [Citation(s) in RCA: 153] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2011] [Revised: 05/25/2011] [Accepted: 06/07/2011] [Indexed: 12/21/2022]  Open
19
Nayak UY, Gopal S, Mutalik S, Ranjith AK, Reddy MS, Gupta P, Udupa N. Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of zidovudine. J Microencapsul 2011;26:214-22. [PMID: 18819029 DOI: 10.1080/02652040802246325] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
20
Danesh-Bahreini MA, Shokri J, Samiei A, Kamali-Sarvestani E, Barzegar-Jalali M, Mohammadi-Samani S. Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice. Int J Nanomedicine 2011;6:835-42. [PMID: 21589651 PMCID: PMC3090280 DOI: 10.2147/ijn.s16805] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2011] [Indexed: 11/23/2022]  Open
21
Chaudhury A, Das S. Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents. AAPS PharmSciTech 2011;12:10-20. [PMID: 21153572 DOI: 10.1208/s12249-010-9561-2] [Citation(s) in RCA: 107] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2010] [Accepted: 11/30/2010] [Indexed: 01/04/2023]  Open
22
Şenel S. Chitosan-Based Particulate Systems for Non-Invasive Vaccine Delivery. ADVANCES IN POLYMER SCIENCE 2011. [DOI: 10.1007/12_2011_120] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
23
Sui Z, Chen Q, Fang F, Zheng M, Chen Z. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant. Vaccine 2010;28:7690-8. [DOI: 10.1016/j.vaccine.2010.09.019] [Citation(s) in RCA: 67] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2010] [Revised: 09/08/2010] [Accepted: 09/09/2010] [Indexed: 01/01/2023]
24
Sui Z, Chen Q, Wu R, Zhang H, Zheng M, Wang H, Chen Z. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant. Arch Virol 2010;155:535-44. [DOI: 10.1007/s00705-010-0621-4] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2009] [Accepted: 01/01/2010] [Indexed: 10/19/2022]
25
Amidi M, Mastrobattista E, Jiskoot W, Hennink WE. Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev 2010;62:59-82. [PMID: 19925837 DOI: 10.1016/j.addr.2009.11.009] [Citation(s) in RCA: 409] [Impact Index Per Article: 27.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2009] [Revised: 10/16/2009] [Accepted: 11/04/2009] [Indexed: 11/28/2022]
26
Progress in chitosan-based vaccine delivery systems. J Drug Deliv Sci Technol 2010. [DOI: 10.1016/s1773-2247(10)50006-6] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
27
Ficht TA, Kahl-McDonagh MM, Arenas-Gamboa AM, Rice-Ficht AC. Brucellosis: the case for live, attenuated vaccines. Vaccine 2009;27 Suppl 4:D40-3. [PMID: 19837284 PMCID: PMC2780424 DOI: 10.1016/j.vaccine.2009.08.058] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2009] [Accepted: 08/11/2009] [Indexed: 10/20/2022]
28
Luo Y, Wang B, Hu L, Yu H, Da Z, Jiang W, Song N, Qie Y, Wang H, Tang Z, Xian Q, Zhang Y, Zhu B. Fusion protein Ag85B-MPT64190–198-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice. Vaccine 2009;27:6179-85. [DOI: 10.1016/j.vaccine.2009.08.018] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2009] [Revised: 07/27/2009] [Accepted: 08/06/2009] [Indexed: 11/24/2022]
29
Ahmad Z, Khuller GK. Alginate-based sustained release drug delivery systems for tuberculosis. Expert Opin Drug Deliv 2008;5:1323-34. [DOI: 10.1517/17425240802600662] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
30
Wang J, Qie Y, Zhang H, Zhu B, Xu Y, Liu W, Chen J, Wang H. PPE protein (Rv3425) from DNA segment RD11 of Mycobacterium tuberculosis: a novel immunodominant antigen of Mycobacterium tuberculosis induces humoral and cellular immune responses in mice. Microbiol Immunol 2008;52:224-30. [PMID: 18426397 DOI: 10.1111/j.1348-0421.2008.00029.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
31
Jones KS. Biomaterials as vaccine adjuvants. Biotechnol Prog 2008;24:807-14. [DOI: 10.1002/btpr.10] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
32
Qie YQ, Wang JL, Zhu BD, Xu Y, Wang QZ, Chen JZ, Wang HH. Evaluation of a new Recombinant BCG which Contains Mycobacterial Antigen ag85B-mpt64190-198-mtb8.4 in C57/BL6 Mice. Scand J Immunol 2008;67:133-9. [DOI: 10.1111/j.1365-3083.2007.02048.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
33
Xie Y, Zhou NJ, Gong YF, Zhou XJ, Chen J, Hu SJ, Lu NH, Hou XH. Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection. World J Gastroenterol 2007;13:1547-1553. [PMID: 17461447 PMCID: PMC4146897 DOI: 10.3748/wjg.v13.i10.1547] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/25/2006] [Revised: 12/28/2006] [Accepted: 02/27/2007] [Indexed: 02/06/2023]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA